Male Hormone Health: A Stanford Doctor's Guide

In 1980, at a urology convention, a pharmacologist gave his scheduled lecture, then lowered his trousers and invited the room to look. He had injected a new drug into himself back in his hotel room to test it, and he wanted his colleagues to see, not just hear, that it worked. Stanford urologist Michael Eisenberg, who leads Stanford's Male Reproductive Medicine and Surgery program, tells this story (59:36) almost as a founding myth for his specialty: the moment a man chose evidence over shame in front of an audience of people whose job is to think about exactly that organ. It sets the tone for the hour he spends on the Mel Robbins Podcast, because nearly everything he says afterward is a variation on the same move: take something men are taught to hide, and hand it back as data.

Eisenberg's framing claim is simple. A man's hormones are not a private inconvenience. They are a preview.

"Men's hormone health is a window into his future health." Michael Eisenberg (00:53)

The anchor hormone is testosterone, and Eisenberg starts by resizing it. The normal range runs from roughly 300 to 390 nanograms per deciliter (08:11), which is wide enough that two healthy men can sit far apart on it. Levels rise through puberty, peak somewhere between ages 20 and 30, then drift down about 1 percent a year (09:00). The decline compounds quietly: about 10 to 20 percent of men in their 40s and 50s test low, climbing to 20 percent in the 60s, 30 percent in the 70s, and by the 80s, roughly half (09:28). That last figure, half of older men running low, is the one Eisenberg wants every man to sit with, because the symptoms it produces (low energy, low libido, poor mood, poor sleep, trouble concentrating) are so vague that most men blame something else: work, age, a bad week.

What Actually Moves the Needle

What struck me about this section of the conversation is how unglamorous the levers turn out to be. Poor sleep blunts the feedback loop between brain and testicle, flattening the normal rhythm of higher testosterone in the morning (18:07), which is why Eisenberg recommends seven to nine hours a night as a baseline for hormonal health (18:33). Excess body fat converts testosterone into estradiol, effectively pulling it out of circulation (19:33), so losing weight through diet and exercise, or through bariatric surgery or GLP-1 medication, reliably nudges levels back up (20:48). Chronic stress triggers cortisol, which tells the body to prioritize survival over everything Eisenberg calls "longevity mode" (21:31), testosterone production included. Heavy drinking blunts the same signaling chain (26:36). None of this is exotic. It is closer to a cardiovascular checklist than an endocrinology one, which is exactly Eisenberg's point when he says, "anything that's good for your heart is good for testosterone" (21:00).

That overlap matters because of what he says next, and it cuts against the current wave of testosterone-clinic marketing. Men with normal levels who go on testosterone anyway are not becoming better versions of themselves, he says; military trials testing testosterone as a performance enhancer found no edge in strength or recovery over placebo once baseline levels were already normal (38:35). What they do get is real risk: lower sperm counts (testosterone was literally tested by the World Health Organization as a male contraceptive, suppressing sperm production about 90 percent of the time, at 35:09), acne, hair loss, breast growth, and higher red blood cell counts that raise clotting risk (39:16). The upside case, for men who are actually deficient, got a major boost from the Traverse Trial, a study of about 5,000 men that found testosterone therapy did not raise the risk of prostate cancer or heart attacks, debunking two fears that had shaped prescribing guidance for years (37:15). The lesson Eisenberg keeps repeating is less a slogan than a filter: get tested, confirm it twice, and treat the number, not the mood.

Beyond the Bedroom

The second half of the conversation turns to erectile dysfunction, and the scale of it surprised even Mel Robbins. The Massachusetts Male Aging Study, run roughly 20 years ago, found that over half of men over 40 have some degree of erectile dysfunction, with prevalence climbing each decade: about 40 percent in the 40s, 50 percent in the 50s, 60 percent in the 60s, 70 percent in the 70s (42:56). Even men in their 20s and 30s show up at 15 to 20 percent (42:56). The mechanism is mostly plumbing: an erection is blood flowing into the penis and staying there, triggered by a chemical called cyclic GMP that dilates blood vessels. Anything that damages blood flow elsewhere, like smoking, diabetes, or high cholesterol, damages it here too (43:35).

Treatment runs in a clear escalation. Pills like Viagra (sildenafil) and Cialis (tadalafil) work first, by blocking the breakdown of that same cyclic GMP (53:49). Cialis lasts far longer in the body, with a half-life of 16 to 18 hours versus Viagra's 6 to 8 (56:00), which is why it is marketed as the weekend pill and why some men take a low dose daily, with emerging observational data (not yet FDA-approved as an indication) suggesting it may be mildly protective for the heart (56:19). If pills fail, a gel or pellet placed in the urethra works 60 to 80 percent of the time (58:19). If that fails, a self-injected vasodilator works about 90 percent of the time (58:52). Eisenberg's bottom line, delivered almost as reassurance, is blunt: "as long as you have a penis, we can always make it hard" (47:32).

He treats sexual function less as a convenience and more as an instrument panel. Men who ejaculate 20 or more times a month show about a 20 percent lower risk of prostate cancer than men who ejaculate less, a pattern seen across a study of roughly 30,000 men followed for 20 years (61:58). Men who have sex once or twice a week tend to live longer than men who rarely do (63:01). And a set of Scandinavian birth-and-death registries found that men without a live-in partner face a 60 percent higher risk of death, men without children face the same 60 percent increase, and men with neither face nearly triple the risk (65:14). Fertility gets the same reframing: sperm counts are falling worldwide, and the rate of decline looks like it is accelerating over the last 20 years (66:43), while a male factor contributes to roughly half of all couples' fertility struggles, a fact that gets lost because, as Eisenberg notes, "usually everybody thinks that all fertility is related to female partner issues" (67:41). Even urination gets folded into the same logic: an enlarged prostate narrowing the urethra explains most nighttime trips to the bathroom, and waking once a night is normal aging, while three or four times is worth a doctor's visit (72:57).

By the end, the throughline is less about testosterone or erections specifically than about a habit of attention. Eisenberg's closing advice is almost anti-climactic: get a baseline blood pressure, cholesterol, and testosterone check, notice what changes, and treat small symptoms as information rather than embarrassment (74:57). The 1980 urologist walking the convention aisles was making an extreme version of the same argument: the fastest way to fix a problem men are ashamed to name is to stop treating the shame as data.